NCT07268365

Brief Summary

High digestive bleeding (HDH) is a medical emergency associated with high morbidity and mortality rates and significant healthcare costs. Upper endoscopy can locate the bleeding and treat it. However, the source of bleeding can be difficult to identify, even for the most experienced endoscopists, due to the location of the bleeding (posterior wall of the bulb, gastric or duodenal folds, papillary region, esophagogastric junction), instability of the tube due to gastric and pyloric contractions and respiratory movements, leading to longer procedure times, hemostasis failure, or even the absence of bleeding visualization. The use of a cap attached to the endoscope facilitates exploration of blind areas of the colonic mucosa located behind folds, thus reducing the rate of missed polyps and cecal intubation time. To date, there is no study evaluating the systematic use of a cap in patients with suspected high digestive bleeding. A series of four cases demonstrated its benefit, allowing for better exposure of the bleeding lesion, better unfolding of intestinal folds, and thus a more effective and quicker hemostatic treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable

Timeline
6mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Oct 2025Nov 2026

Study Start

First participant enrolled

October 16, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 17, 2025

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 5, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

December 5, 2025

Status Verified

November 1, 2025

Enrollment Period

12 months

First QC Date

November 17, 2025

Last Update Submit

November 25, 2025

Conditions

Keywords

Cap-assisted endoscopyupper gastro intestinal bleedingendoscopy

Outcome Measures

Primary Outcomes (1)

  • procedure time until endoscopic hemostasis is achieved

    procedure time until endoscopic hemostasis is achieved

    1 month

Secondary Outcomes (7)

  • therapeutic success rate

    1 month

  • clinical success rate

    1 month

  • time until bleeding localization

    up to 1 month

  • duration of hemostasis achievement

    up to 1 month

  • endoscope stability

    up to 1 month

  • +2 more secondary outcomes

Study Arms (2)

standard upper endoscopy

ACTIVE COMPARATOR

standard upper endoscopy

Procedure: upper endoscopy

CAP

EXPERIMENTAL

upper endoscopy with the placement of an endoscopic cap

Procedure: upper endoscopyProcedure: CAP

Interventions

All patients with the inclusion criteria will be randomized (randomization 1:1) to undergo either an upper endoscopy with an endoscopic cap or without a cap

CAPstandard upper endoscopy
CAPPROCEDURE

All patients with the inclusion criteria will be randomized (randomization 1:1) to undergo either an upper endoscopy with an endoscopic cap or without a cap

CAP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient \> 18 years old
  • Upper GI bleeding suspected in presence of melena or hematemesis
  • Glasgow Blatchford score \> 8
  • Upper gastroscopy at Amiens University Hospital
  • Follow-up at Amiens university hospital
  • Presence of gastric or duodenal ulcer requiring endoscopic hemostasis (FORREST Ia, Ib, IIa, IIb)
  • No opposition to the study
  • No guardianship or curators

You may not qualify if:

  • Patient with clinical suspicion of portal hypertension
  • Known liver failure
  • Patient with digestive hemorrhage related to a lesion located beyond the 2nd duodenum
  • Patient with digestive hemorrhage related to a varicose lesion (esophageal or gastric varices)
  • Patient with bleeding associated with esophagitis
  • Patient with bleeding associated with angiodysplasias

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire d'Amiens

Amiens, Picardie, 80000, France

RECRUITING

MeSH Terms

Conditions

Gastrointestinal Hemorrhage

Interventions

Gastroscopy

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2025

First Posted

December 5, 2025

Study Start

October 16, 2025

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

December 5, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations